Vanguard Group
NXTM

Vanguard Group’s NxStage Medical Inc. NXTM Stock Holding History

Vanguard Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,148,544
Closed -$176M – 4151
2018
Q4 		$176M Buy
6,148,544
+177,798
+3% +$5.05M 0.01% 1319
2018
Q3 		$167M Buy
5,970,746
+101,806
+2% +$2.86M 0.01% 1515
2018
Q2 		$164M Buy
5,868,940
+177,153
+3% +$4.75M 0.01% 1484
2018
Q1 		$141M Buy
5,691,787
+204,929
+4% +$4.98M 0.01% 1517
2017
Q4 		$133M Buy
5,486,858
+107,550
+2% +$2.83M 0.01% 1560
2017
Q3 		$148M Buy
5,379,308
+155,963
+3% +$4.16M 0.01% 1472
2017
Q2 		$131M Sell
5,223,345
-50,417
-1% -$1.25M 0.01% 1516
2017
Q1 		$141M Buy
5,273,762
+412,233
+8% +$11.4M 0.01% 1457
2016
Q4 		$127M Buy
4,861,529
+149,086
+3% +$3.69M 0.01% 1472
2016
Q3 		$118M Buy
4,712,443
+109,904
+2% +$2.56M 0.01% 1455
2016
Q2 		$99.8M Buy
4,602,539
+478,459
+12% +$8.54M 0.01% 1520
2016
Q1 		$61.8M Buy
4,124,080
+126,929
+3% +$2.13M ﹤0.01% 1763
2015
Q4 		$87.6M Buy
3,997,151
+116,061
+3% +$2.16M 0.01% 1556
2015
Q3 		$61.2M Buy
3,881,090
+132,385
+4% +$2.12M ﹤0.01% 1756
2015
Q2 		$53.6M Buy
3,748,705
+107,077
+3% +$1.81M ﹤0.01% 1905
2015
Q1 		$63M Buy
3,641,628
+206,379
+6% +$3.65M ﹤0.01% 1800
2014
Q4 		$61.6M Buy
3,435,249
+34,924
+1% +$562K ﹤0.01% 1716
2014
Q3 		$44.6M Buy
3,400,325
+24,418
+0.7% +$329K ﹤0.01% 1862
2014
Q2 		$48.5M Sell
3,375,907
-18,970
-0.6% -$248K ﹤0.01% 1844
2014
Q1 		$43.3M Buy
3,394,877
+44,883
+1% +$585K ﹤0.01% 1879
2013
Q4 		$33.5M Buy
3,349,994
+146,462
+5% +$1.66M ﹤0.01% 1970
2013
Q3 		$42.2M Buy
3,203,532
+117,210
+4% +$1.54M ﹤0.01% 1818
2013
Q2 		$44.1M Buy
+3,086,322
New +$38.8M ﹤0.01% 1709

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Vanguard Group's NXTM Position: Q1 2019 in Review

Vanguard Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 6,148,544 shares — an estimated $176M sold.

Vanguard Group first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $176M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Vanguard Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Vanguard Group sold 6,148,544 NxStage Medical Inc. shares in Q1 2019, an estimated $176M.
  • Vanguard Group first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • Vanguard Group's NxStage Medical Inc. position peaked at $176M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Vanguard Group's 13F filing for Q1 2019, filed 15 May 2019.